Product Information

CAPTOPRIL 12.5 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.2295 per EA under NDC 27241016001. Its NADAC has been published 306 times since Oct 14, 2020.

FDA first approved this application on Dec 13, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CAPTOPRIL 12.5 MG TABLET

Captopril
$0.2295per EA

Strength

12.5 mg/1

NDC

27241016001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CAPTOPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA212809

FDA Approved

12/13/2019

TE Code

AB

On Market Since

12/13/2019

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for CAPTOPRIL 12.5 MG TABLET has been published 306 times since Oct 14, 2020, and over the history we have for it it has declined 69.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2295 per EA
All-time high$0.7541 (Dec 16, 2020)
All-time low$0.1816 (Mar 19, 2025)
52-week high$0.4059
52-week low$0.2295
Median price$0.4272
Average price$0.4365
Largest weekly change+125.8% (Aug 17, 2022)
Weeks tracked306
Tracking sinceOct 14, 2020

Price History

1W

-9.3%

1M

-9.3%

3M

-17.0%

6M

-31.0%

1Y

-20.4%

3Y

-53.0%

5Y

-45.2%

All

-69.6%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CAPTOPRIL 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CAPTOPRIL 12.5 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.2295 per EA (NDC 27241016001), effective Aug 19, 2026.

How has the price of CAPTOPRIL 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CAPTOPRIL 12.5 MG TABLET has declined 69.6%. It has been tracked across 306 weekly CMS publications since Oct 14, 2020.

What are the highest and lowest recorded NADAC prices for CAPTOPRIL 12.5 MG TABLET?

Since Oct 14, 2020, the NADAC for CAPTOPRIL 12.5 MG TABLET has ranged from a low of $0.1816 (Mar 19, 2025) to a high of $0.7541 (Dec 16, 2020), with a median of $0.4272 per EA.

Are there cheaper alternatives to CAPTOPRIL 12.5 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CAPTOPRIL 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CAPTOPRIL 12.5 MG TABLET?

CAPTOPRIL 12.5 MG TABLET (NDC 27241016001) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.